Aducanumab Accelerated Approval Reflects US FDA Flexibility But Raises Doubts About Confirmatory Trial

 
• By Sue Sutter
Rabbit in hat
US FDA pulled a rabbit out of a hat with its surprise use of the accelerated approval pathway for aducanumab. • Source: Alamy

More from Approvals

More from Product Reviews